About
Gh Research Plc (NASDAQ:GHRS) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
Mar 25 2026
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
Mar 5 2026
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
Jan 5 2026
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
Jan 2 2026
GH Research to Announce IND Status for GH001
Financials
Revenue
$0
Market Cap
$903.77 M
EPS
-0.79
